Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells

Journal of Clinical Investigation

Volumn 100, Issue 8, 1997, Pages 2054-2061

  Shibutani, Tomoko ^a   Johnson, Thomas M ^a   Yu, Zu Xi ^a   Ferrans, Victor J ^a   Moss, Joel ^a   Epstein, Stephen E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Arachidonic acid; Cytosolic phospholipase A2; Mitogen activated protein kinase; Nuclear factor B; Reactive oxygen species

Indexed keywords

ARACHIDONIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHOLIPASE A2; REACTIVE OXYGEN METABOLITE;

ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VIRUS INFECTION;

EID: 0030772187     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119738     Document Type: Article

References (35)

1. Melnick, J.L., E. Adam, and M.E. Debakey. 1993. Cytomegalovirus and atherosclerosis. Eur. Heart J. 14(Suppl. K):30-38.
2. Alford, C.A., and W.J. Britt. 1990. Cytomegalovirus. In Virology. B.N. Fields and D.M. Knipe, editors. Raven Press, Inc., New York. 1981-2010
3. Speir, E., R. Modali, E.S. Huang, M.B. Leon, F. Shawl, T. Finkel, and S.E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (Wash. DC). 265:391-394.
4. Zhou, Y.F., M.B. Leon, M.A. Waclawiw, J.J. Popma, Z.X. Yu, T. Finkel, and S.E. Epstein. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:624-630.
5. Ross, R., and V. Fuster. 1996. The pathogenesis of atherosclerosis. In Atherosclerosis and Coronary Artery Disease. V. Fuster, R. Ross, and E.J. Topol, editors. Lippincott-Raven Publishers, Philadelphia. 441-460.
6. Speir, E., T. Shibutani, Z.X. Yu, V.J. Ferrance, and S.E. Epstein. 1996. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ. Res. 79: 1143-1152.
7. Speir, E., T. Shibutani, Z.X. Yu, and S.E. Epstein. 1995. Aspirin, by inhibiting free radical generation induced by cytomegalovirus infection of human smooth muscle cells, inhibits cytomegalovirus gene expression and cytomegalovirus replication. Circulation. 92(Suppl. I):229. (Abstr.)
8. Freeman, B.A., and J.D. Crapo. 1982. Biology of disease-free radicals and tissue injury. Lab. Invest. 47:412-426.
9. 2-mediated signaling in neutrophils. Biochim. Biophys. Acta. 1113:135-160.
10. Ali, N., and D.K. Agrawal. 1994. Guanine nucleotide binding regulatory proteins: their characteristics and identification. J. Pharmacol. Toxicol. Methods. 32:187-196.
11. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA. 89:6147-6151.
12. 2. Eur. J. Biochem. 230:164-169.
13. 2+ and mitogen-activated protein kinase regulation J. Biol. Chem. 269:1889-1895.
14. Albrecht, T., M.P. Fons, I. Boldogh, S. AbuBakar, C.Z. Deng, and D. Millinoff. 1991. Metabolic and cellular effects of human cytomegalovirus infection. Transplant. Proc. 23(Suppl. 3):48-54.
15. 2 is phosphorylated and activated by MAP kinase. Cell. 72:269-278.
16. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1960-1964.
17. Huang, E.S. 1975. Human cytomegalovirus. III. Virus-induced DNA polymerase. J. Virol. 16:298-310.
18. Rappuoli, R., A. Podda, M. Pizza, A. Covacci, A. Bartoloni, M.T. Magistris, and L. Nencioni. 1992. Progress towards the development of new vaccines against whooping cough. Vaccine. 10:1027-1032.
19. Alessi, D.R., A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
20. Dudley, D.T., L. Pang, S.J. Decker, A.J. Bridges, and A.R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:7686-7689.
21. Pang, L., T. Sawada, S.J. Decker, and A.R. Saltiel. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:13585-13588.
22. 2 for platelet-derived growth factor signal transduction. Science (Wash. DC) 270:296-299.
23. Staal, F.J.T., M. Roederer, L.A. Herzenberg, and L.A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:9943-9947.
24. 2. J. Clin. Invest. 96:733-740.
25. 2. J. Biol. Chem. 269:13057-13060.
26. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270:30749-30754.
27. 2. Biochim. Biophys. Acta. 1259:125-136.
28. 2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 91:3142-3146.
29. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem. 270:2360-2366.
30. Faure, M., T.A. Voyno-Yasenetskaya, and H.R. Bourne. 1994. cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269:7851-7854.
31. Wan, Y., T. Kurosaki, and X.Y. Huang. 1996. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature (Lond.). 380:541-544.
32. Crews, C.M., A. Alessandrini, and R.L. Erikson. 1992. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science (Wash. DC). 258:478-480.
33. Tamura, M., K. Nogimori, M. Yajima, K. Ase, and M. Ui. 1983. A role of the B oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J. Biol. Chem. 258:6756-6761.
34. Kaslow, H.R., and D.L. Burns. 1992. Pertussis toxin and target eukaryotic cells: binding, entry and activation. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6: 2684-2690.
35. Baldwin, B.R., M. Kleinberg, and S. Keay. 1996. Molecular cloning and expression of receptor peptides that block human cytomegalovirus/cell fusion. Biochem. Biophys. Res. Commun. 219:668-673.